AndreaBozzo/ceres-open-data-index huggingface dataset:
NNDSS - Table II. Shiga toxin to Shigellosis

NNDSS - Table II. Shiga toxin to Shigellosis - 2016.  In this Table, provisional* cases of selected† notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories.
Note:
These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. 

Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. 

Footnotes:
C.N.M.I.: Commonwealth of Northern Mariana Islands. 
U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable.   NP:  Nationally notifiable but not published.   Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum.
 
* Case counts for reporting year 2016 are provisional and subject to change.   For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf.   Data for TB are displayed in Table IV, which appears quarterly.  
† Three low incidence conditions, rubella, rubella congenital, and tetanus, have been moved to Table II to facilitate case count verification with reporting jurisdictions.
§ Includes E. coli O157:H7; Shiga toxin-positive, serogroup non-O157; and Shiga toxin-positive, not serogrouped.

Tags: 2016, mmwr, nedss, netss, nndss, shiga-toxin-producing-e-coli, shigellosis, stec, wonder
Organization: U.S. Department of Health & Human Services
NNDSS - Table II. Shiga toxin to Shigellosis

NNDSS - Table II. Shiga toxin to Shigellosis - 2015.  In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories. Note:These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. Footnotes:C.N.M.I.: Commonwealth of Northern Mariana Islands. U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable.    NP: Nationally notifiable but not published.    Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum. * Three low incidence conditions, rubella, rubella congenital, and tetanus, have been moved to Table 2 to facilitate case count verification with reporting jurisdictions. ��� Case counts for reporting year 2015 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly. �� Includes E. coli O157:H7; Shiga toxin-positive, serogroup non-O157; and Shiga toxin-positive, not serogrouped.

Tags: 2015, mmwr, nedss, netss, nndss, shiga-toxin-producing-e-coli, shigellosis, stec, wonder
Organization: U.S. Department of Health & Human Services
U.S. State and Territorial Public Mask Mandates From April 10, 2020 through August 15, 2021 by County by Day

State and territorial executive orders, administrative orders, resolutions, and proclamations are collected from government websites and cataloged and coded using Microsoft Excel by one coder with one or more additional coders conducting quality assurance.

Data were collected to determine when members of the public in states and territories were subject to state and territorial executive orders, administrative orders, resolutions, and proclamations for COVID-19 that require them to wear masks in public. “Members of the public” are defined as individuals operating in a personal capacity. “In public” is defined to mean either (1) anywhere outside the home or (2) both in retail businesses and in restaurants/food establishments. Data consists exclusively of state and territorial orders, many of which apply to specific counties within their respective state or territory; therefore, data is broken down to the county level. 

These data are derived from publicly available state and territorial executive orders, administrative orders, resolutions, and proclamations (“orders”) for COVID-19 that expressly require individuals to wear masks in public found by the CDC, COVID-19 Community Intervention & Critical Populations Task Force, Monitoring & Evaluation Team, Mitigation Policy Analysis Unit, Center for State, Tribal, Local, and Territorial Support, Public Health Law Program, and Max Gakh, Assistant Professor, School of Public Health, University of Nevada, Las Vegas from April 10, 2020 through August 15, 2021.  These data will be updated as new orders are collected. Any orders not available through publicly accessible websites are not included in these data. Only official copies of the documents or, where official copies were unavailable, official press releases from government websites describing requirements were coded; news media reports on restrictions were excluded. Recommendations not included in an order are not included in these data. Effective and expiration dates were coded using only the dates provided; no distinction was made based on the specific time of the day the order became effective or expired. These data do not include data on counties that have opted out of their state mask mandate pursuant to state law. These data do not necessarily represent an official position of the Centers for Disease Control and Prevention.

Tags: covid-19, executive-order, government-order, legal-epidemiology, mask-mandates, masks, mitigation, proclamation, public-health-order, social-distancing
Organization: U.S. Department of Health & Human Services
PLACES: ZCTA Data (GIS Friendly Format), 2020 release

This dataset contains model-based ZIP Code tabulation Areas (ZCTA) level estimates for the PLACES project 2020 release in GIS-friendly format. The PLACES project is the expansion of the original 500 Cities project and covers the entire United States—50 states and the District of Columbia (DC)—at county, place, census tract, and ZIP Code tabulation Areas (ZCTA) levels. It represents a first-of-its kind effort to release information uniformly on this large scale for local areas at 4 geographic levels. Estimates were provided by the Centers for Disease Control and Prevention (CDC), Division of Population Health, Epidemiology and Surveillance Branch. The project was funded by the Robert Wood Johnson Foundation (RWJF) in conjunction with the CDC Foundation. Data sources used to generate these model-based estimates include Behavioral Risk Factor Surveillance System (BRFSS) 2018 or 2017 data, Census Bureau 2010 population estimates, and American Community Survey (ACS) 2014-2018 or 2013-2017 estimates. The 2020 release uses 2018 BRFSS data for 23 measures and 2017 BRFSS data for 4 measures (high blood pressure, taking high blood pressure medication, high cholesterol, and cholesterol screening). Four measures are based on the 2017 BRFSS data because the relevant questions are only asked every other year in the BRFSS. These data can be joined with the census 2010 ZCTA boundary file in a GIS system to produce maps for 27 measures at the ZCTA level. An ArcGIS Online feature service is also available at https://www.arcgis.com/home/item.html?id=8eca985039464f4d83467b8f6aeb1320 for users to make maps online or to add data to desktop GIS software.

Tags: behaviors, gis, outcomes, places, prevalence, prevention, unhealthy, zcta, zip-code
Organization: U.S. Department of Health & Human Services
500 Cities: Local Data for Better Health, 2019 release

This is the complete dataset for the 500 Cities project 2019 release. This dataset includes 2017, 2016 model-based small area estimates for 27 measures of chronic disease related to unhealthy behaviors (5), health outcomes (13), and use of preventive services (9). Data were provided by the Centers for Disease Control and Prevention (CDC), Division of Population Health, Epidemiology and Surveillance Branch. The project was funded by the Robert Wood Johnson Foundation (RWJF) in conjunction with the CDC Foundation. It represents a first-of-its kind effort to release information on a large scale for cities and for small areas within those cities. It includes estimates for the 500 largest US cities and approximately 28,000 census tracts within these cities. These estimates can be used to identify emerging health problems and to inform development and implementation of effective, targeted public health prevention activities. Because the small area model cannot detect effects due to local interventions, users are cautioned against using these estimates for program or policy evaluations. Data sources used to generate these measures include Behavioral Risk Factor Surveillance System (BRFSS) data (2017, 2016), Census Bureau 2010 census population data, and American Community Survey (ACS) 2013-2017, 2012-2016 estimates. Because some questions are only asked every other year in the BRFSS, there are 7 measures (all teeth lost, dental visits, mammograms, pap tests, colorectal cancer screening, core preventive services among older adults, and sleep less than 7 hours) from the 2016 BRFSS that are the same in the 2019 release as the previous 2018 release. More information about the methodology can be found at www.cdc.gov/500cities.

Tags: 500cities, behaviors, brfss, census, cities, outcomes, prevalence, prevention, tracts, unhealthy
Organization: U.S. Department of Health & Human Services
500 Cities: Census Tract-level Data (GIS Friendly Format), 2018 release

2016, 2015. Data were provided by the Centers for Disease Control and Prevention (CDC), Division of Population Health, Epidemiology and Surveillance Branch. The project was funded by the Robert Wood Johnson Foundation (RWJF) in conjunction with the CDC Foundation. 500 cities project census tract-level data in GIS-friendly format can be joined with census tract spatial data (https://chronicdata.cdc.gov/500-Cities/500-Cities-Census-Tract-Boundaries/x7zy-2xmx) in a geographic information system (GIS) to produce maps of 27 measures at the census tract level. There are 4 measures (high blood pressure, taking high blood pressure medication, high cholesterol, cholesterol screening) in this 2018 release from the 2015 BRFSS that were the same as the 2017 release.

Tags: 500cities, behaviors, census, cities, gis, outcomes, prevalence, prevention, tract, unhealthy
Organization: U.S. Department of Health & Human Services
NNDSS - Table II. Chlamydia to Coccidioidomycosis

NNDSS - Table II. Chlamydia to Coccidioidomycosis - 2016.  In this Table, provisional* cases of selected† notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories.
Note:
These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. 

Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. 

Footnotes:
C.N.M.I.: Commonwealth of Northern Mariana Islands. 
U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable.    NP:  Nationally notifiable but not published.  Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum.

* Case counts for reporting year 2016 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly. 
† Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions.

Tags: 2016, chlamydia-trachomatis-infection, coccidioidomycosis, mmwr, nedss, netss, nndss, wonder
Organization: U.S. Department of Health & Human Services
NNDSS - Table II. Salmonellosis to Shigellosis

NNDSS - Table II. Salmonellosis to Shigellosis - 2014.In this Table, all conditions with a 5-year average annual national total of more than or equals 1,000 cases but less than or equals 10,000 cases will be displayed (��� 1,000 and ��_ 10,000). The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories. Note:These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. Footnotes:C.N.M.I.: Commonwealth of Northern Mariana Islands. U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable    Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum. * Case counts for reporting years 2013 and 2014 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly. ��� Includes E. coli O157:H7; Shiga toxin positive, serogroup non-O157; and Shiga toxin positive, not serogrouped.More information on NNDSS is available at http://wwwn.cdc.gov/nndss/.

Tags: 2014, mmwr, nedss, netss, nndss, salmonellosis, shiga-toxin-producing-e-coli, shigellosis, stec, wonder
Organization: U.S. Department of Health & Human Services
NNDSS - Table II. Ehrlichiosis/Anaplasmosis

NNDSS - Table II. Ehrlichiosis/Anaplasmosis - 2016.  In this Table, provisional* cases of selected† notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories. 

Note:
These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. 

Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. 

Footnotes:
C.N.M.I.: Commonwealth of Northern Mariana Islands. 
U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable.   NP:  Nationally notifiable but not published.   Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum.
 
* Case counts for reporting year 2016 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly. 
† Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions. 
§ Please refer to the MMWR publication for weekly updates to the footnote for this condition.

Tags: 2016, anaplasma-phagocytophilum, ehrlichia-chaffeensis, ehrlichiosis-anaplasmosis, mmwr, nedss, netss, nndss, undetermined, wonder
Organization: U.S. Department of Health & Human Services
CDC Best Practices for Comprehensive Tobacco Control Programs - 2014

2014. Centers for Disease Control and Prevention (CDC). Best Practices for Comprehensive Tobacco Control Programs. Funding. CDC's Best Practices for Comprehensive Tobacco Control Programs is an evidence-based guide to help states plan and establish effective tobacco control programs to prevent and reduce tobacco use.  These data update Best Practices for Comprehensive Tobacco Control Programs—2007.  Data are reported at total and per capita funding levels. Data include recommended and minimum total funding levels for state programs, in addition to funding breakdowns by intervention areas such as: State and Community Interventions, Mass-Reach Health Communication Interventions, Cessation Interventions, Surveillance and Evaluation, and Infrastructure, Administration, and Management.

Tags: administration-and-management, best-practices, best-practices-for-comprehensive-tobacco-control-programs, centers-for-disease-control-and-prevention, cessation-intervention, health-communication-interventions, office-on-smoking-and-health, osh, state-and-community-interventions, surveillance-and-evaluation, tobacco
Organization: U.S. Department of Health & Human Services
NNDSS - Table II. Hepatitis (viral, acute)

NNDSS - Table II. Hepatitis (viral, acute) - 2015.In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed.The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories. Note:These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. Footnotes:C.N.M.I.: Commonwealth of Northern Mariana Islands. U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable.    NP: Nationally notifiable but not published.    Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum. * Three low incidence conditions, rubella, rubella congenital, and tetanus, have been moved to Table 2 to facilitate case count verification with reporting jurisdictions. ��� Case counts for reporting year 2015 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly.

Tags: 2015, hepatitis, hepatitis-viral-acute, hepatitis-viral-acute-type-a, hepatitis-viral-acute-type-b, hepatitis-viral-acute-type-c, mmwr, nedss, netss, nndss, wonder
Organization: U.S. Department of Health & Human Services
NNDSS - Table II. Babesiosis to Campylobacteriosis

NNDSS - Table II. Babesiosis to Campylobacteriosis - 2018. In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states or territory.

Note:

This table contains provisional cases of selected national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up.  Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html 

Footnotes:

 C.N.M.I.: Commonwealth of Northern Mariana Islands. 
U: Unavailable. —: No reported cases. N: Not reportable. NA:  Not Available.  NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum. 

* Case counts for reporting years 2017 and 2018 are provisional and subject to change. Data for years 2013 through 2016 are finalized. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf.

Tags: 2018, babesiosis, campylobacteriosis, nedss, netss, nndss, wonder
Organization: U.S. Department of Health & Human Services